Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  International Business Machines Corporation    IBM

INTERNATIONAL BUSINESS MACHINES CORPORATION

(IBM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

International Business Machines : DarwinAI and Red Hat Team Up to Bring COVID-Net Radiography Screening AI to Hospitals, Using Underlying Technology from Boston Children's Hospital

11/17/2020 | 06:44am EST

Deep learning-based screening tool can help triage COVID-19 cases.

DarwinAI, the explainable artificial intelligence (XAI) company, and Red Hat, the world's leading provider of open source solutions, today announced a collaboration to accelerate the deployment of COVID-Net-a suite of deep neural networks for COVID-19 detection and risk stratification via chest radiography-to hospitals and other healthcare facilities. DarwinAI and Red Hat are also leveraging the expertise of a computation research group, the Fetal Neonatal Neuroimaging and Developmental Science Center (FNNDSC) at Boston Children's Hospital to better focus the software for real world clinical and research use.

COVID-19 impacts us all, and we are proud to have Red Hat OpenShift be an underlying technology in COVID-Net, a platform designed to better help frontline healthcare workers when it comes to understanding this complex disease.

CHRIS WRIGHTSENIOR VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER, RED HAT

Since the launch of COVID-Net by DarwinAI and the University of Waterloo'sVision and Imaging Processing (VIP) Lab , the project has continued to evolve with assistance, participation and collaboration from researchers and clinicians around the world. The initiative eventually led to a collaboration between DarwinAI and Red Hat, using underlying technology from Boston Children's, the number one pediatric hospital in the nation.

The goal of this collaboration is to make it easier for clinicians to use COVID-Net in hospitals by means of a web-based graphical user interface (GUI) that sits atop Boston Children's ChRIS framework using Red Hat OpenShift - the industry's leading enterprise Kubernetes platform that supports deployments across complex hybrid and multicloud infrastructures.

'Improving clinical care and outcomes through cutting edge computational research is core to the mission of Boston Children's FNNDSC. Our open source ChRIS platform allows for the rapid development and deployment of novel AI solutions in practically any setting,' said Boston Children's Scientist Rudolph Pienaar, Ph.D., lead Technical Architect of ChRIS and Assistant Professor in Radiology at Harvard Medical School. 'We are thrilled to help deploy COVID-Net on ChRIS with DarwinAI and leverage Red Hat OpenShift. We believe this effort can result in screening many cases at tremendous scale and help focus healthcare where it is most needed as quickly as possible.'

'Our mission is to help people build AI they can trust, and the development of COVID-Net is a topical and timely manifestation of that goal,' said Sheldon Fernandez, DarwinAI's CEO. 'The COVID-Net system is a promising tool, but needs to be coupled with a compelling GUI to be effective - Boston Children's ChRIS framework and the Red Hat OpenShift platform provides an effective way to get COVID-Net into the hands of health care professionals on the front lines'.

'At Red Hat, we pride ourselves on our open technologies hybrid cloud being used for the greater good,' said Chris Wright, senior vice president and chief technology officer, Red Hat. 'COVID-19 impacts us all, and we are proud to have Red Hat OpenShift be an underlying technology in COVID-Net, a platform designed to better help frontline healthcare workers when it comes to understanding this complex disease.'

About COVID-Net

As the first wave of the COVID-19 pandemic took hold, the medical community reported one of the largest bottlenecks in triage and diagnosis was the scarcity and turn around time of the standard RT-PCR viral test. In response, DarwinAI collaborated with researchers at the University of Waterloo'sVision and Imaging Processing (VIP) Lab to develop COVID-Net as a complementary tool to assist clinicians in rapidly screening for COVID-19 and assessing disease progression and severity.

DarwinAI's Generative Synthesis platform enabled its team to develop COVID-Net in under a week, and on March 22 it was open-sourced and made publicly available to the research and international clinical community. The COVID-Net initiative has received global support and contribution from around 20 clinical institutes and healthcare providers around the world including Canada, U.S., Spain, India, and Malaysia.

About DarwinAI

DarwinAI, an explainable AI company, enables enterprises to build AI they can trust. Founded by renowned academics at the University of Waterloo, DarwinAI's Generative Synthesis technology makes explainability real, allowing developers to understand, interpret, and quantify the inner workings of a deep neural network. Based on years of distinguished scholarship, the company's patented explainability technology accelerates advanced deep learning design and unlocks new possibilities for the commercial uses of deep learning. Learn more at https://www.darwinai.com/.

About Boston Children's Hospital

Boston Children's Hospital is ranked the #1 children's hospital in the nation by U.S. News & World Report and is the primary pediatric teaching affiliate of Harvard Medical School. Home to the world's largest research enterprise based at a pediatric medical center, its discoveries have benefited both children and adults since 1869. Today, 3,000 researchers and scientific staff, including 9 members of the National Academy of Sciences, 21 members of the National Academy of Medicine and 12 Howard Hughes Medical Investigators comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's is now a 415-bed comprehensive center for pediatric and adolescent health care. For more, visit our Discoveries blog and follow us on social media @BostonChildrens, BCH_Innovation, Facebook and YouTube.

ABOUT RED HAT

Red Hat is the world's leading provider of enterprise open source software solutions, using a community-powered approach to deliver reliable and high-performing Linux, hybrid cloud, container, and Kubernetes technologies. Red Hat helps customers integrate new and existing IT applications, develop cloud-native applications, standardize on our industry-leading operating system, and automate, secure, and manage complex environments. Award-winning support, training, and consulting services make Red Hat a trusted adviser to the Fortune 500. As a strategic partner to cloud providers, system integrators, application vendors, customers, and open source communities, Red Hat can help organizations prepare for the digital future.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this press release may constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company or its parent International Business Machines Corporation (NYSE:IBM) may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of this press release.

Red Hat, Red Hat Enterprise Linux, the Red Hat logo, JBoss, Ansible, Ceph, CloudForms, Gluster and OpenShift are trademarks or registered trademarks of Red Hat, Inc. or its subsidiaries in the U.S. and other countries. Linux is the registered trademark of Linus Torvalds in the U.S. and other countries. The OpenStack Word Mark is either a registered trademark/service mark or trademark/service mark of the OpenStack Foundation, in the United States and other countries, and is used with the OpenStack Foundation's permission. Red Hat is not affiliated with, endorsed or sponsored by the OpenStack Foundation, or the OpenStack community.

IN SHORT

Red Hat collaborates with DarwinAI and Boston Children's Hospital to create a platform designed to better help healthcare workers combat COVID-19.

(C) 2020 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
INTERNATIONAL BUSINESS MACHINES CORPORATION -0.45% 128.39 Delayed Quote.1.99%
All news about INTERNATIONAL BUSINESS MACHINES CORPORATION
09:15aINTERNATIONAL BUSINESS MACHINES CORP : annual earnings release
01/14INTERNATIONAL BUSINESS MACHINES : Larsen & Toubro Infotech Expand Global Allianc..
MT
01/14INTERNATIONAL BUSINESS MACHINES : IBM to Acquire Taos for Undisclosed Sum
MT
01/14IBM : Boosts Its Hybrid Cloud Consulting Capability with Taos
PR
01/14IBM to Acquire Cloud Computing Consultant Taos Mountain
DJ
01/14VONAGE : Appoints Jay Bellissimo Chief Operating Officer
MT
01/14IBM : Helps Audi UK Reimagine the Digital Customer Experience
PR
01/13INTERNATIONAL BUSINESS MACHINES : Covalent Taps IBM Blockchain to Help Track the..
PR
01/12INTERNATIONAL BUSINESS MACHINES : IBM Tops U.S. Patent List for 28th Consecutive..
PR
01/11INTERNATIONAL BUSINESS MACHINES : IBM Buys 7Summits for Undisclosed Sum
MT
More news
Financials (USD)
Sales 2020 73 943 M - -
Net income 2020 5 393 M - -
Net Debt 2020 53 023 M - -
P/E ratio 2020 21,4x
Yield 2020 5,06%
Capitalization 114 B 114 B -
EV / Sales 2020 2,26x
EV / Sales 2021 2,19x
Nbr of Employees 352 600
Free-Float 39,7%
Chart INTERNATIONAL BUSINESS MACHINES CORPORATION
Duration : Period :
International Business Machines Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTERNATIONAL BUSINESS MACHINES CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 137,50 $
Last Close Price 128,39 $
Spread / Highest target 24,6%
Spread / Average Target 7,10%
Spread / Lowest Target -8,87%
EPS Revisions
Managers and Directors
NameTitle
Arvind Krishna Chairman & Chief Executive Officer
James M. Whitehurst President, Head-Strategy, Cloud & Cognitive
James J. Kavanaugh Chief Financial Officer & Senior Vice President
Juan Antonio Zufiria Senior VP-IBM Global Technology Services
Fletcher Previn Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
INTERNATIONAL BUSINESS MACHINES CORPORATION1.99%114 403
TATA CONSULTANCY SERVICES12.95%163 507
ACCENTURE PLC-2.89%160 874
INFOSYS LIMITED7.10%78 019
AUTOMATIC DATA PROCESSING, INC.-8.56%69 091
VMWARE, INC.-3.89%56 590